ORANGEBURG, N.Y., March 6, 2013 (GLOBE NEWSWIRE) -- Vision-Sciences, Inc. (Nasdaq:VSCI), a leading provider of unique flexible endoscopic products utilizing its proprietary sterile disposable EndoSheath® technology, today announced that Cynthia Ansari, President and Chief Executive Officer, will present at 4:00 PM Central Standard Time at the Canaccord Genuity Musculoskeletal Conference in Chicago on Tuesday, March 19th at the Westin Michigan Avenue.
The presentation will also be available via a live audio webcast at the following link: http://www.wsw.com/webcast/canaccord9 .
Following the presentation, a replay will be available through Vision-Sciences' website at www.visionsciences.com under the "Investor Relations" section and will remain available for thirty days after the actual presentation date.
About Vision-Sciences, Inc.
Vision-Sciences, Inc. designs, develops, manufactures and markets products for flexible endoscopy. Vision-Sciences' unique flexible endoscopic products utilize a streamlined visualization system and proprietary sterile disposable microbial barrier, known as EndoSheath technology, to provide users quick, efficient endoscope turnover while ensuring enhanced patient safety through the use of sterile, single-use technology. Within its medical segment, Vision-Sciences targets five main areas for its fiber and video endoscopes and EndoSheath technology: urology, pulmonology, gastroenterology (GI), ENT (ear, nose and throat) and spine. Information about Vision-Sciences' products is available at www.visionsciences.com .
Vision Sciences®, Slide-On®, EndoSheath®, EndoWipe® and The Vision System® are registered trademarks of Vision-Sciences, Inc.
The Vision-Sciences, Inc. logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=3876
CONTACT: Keith Darragh VP, Finance and Principal Financial and Accounting Officer Vision-Sciences, Inc. (845) 365-0600 email@example.com Lisa Wilson President In-Site Communications, Inc. (212) 452-2793 firstname.lastname@example.org
© Copyright 2012, GlobeNewswire, Inc. All Rights Reserved